Home > Inhaler Testing > Improving IVIVCs > Facemask Testing > Nebulisers > APSD

Facemask Testing

One of the main factors influencing the amount of inhaled drug available to the patient is the interface between the facemask and the patient. Investigating and defining the effect of a facemask to the product’s DDU and APSD is important for the product development.

Spacers/VHCs

Nebulisers

Spacers/VHCs

Nebulisers

Please select an option:

DDU APSD

View Brochure

Please select an option:

DDU APSD

View Brochure

Related Services

Training

We offer a range of training courses, presentations and seminars covering a wide range of topics.

Find Out More

Servicing

A comprehensive range of both in-house and on-site product servicing options are available

Find Out More

Support

Our team of experienced technicians and engineers are on hand to help and advise

Find Out More

Facemask Testing

Related Services

Training

Servicing

Support

Related News & Resources

Introducing the Copley Impactor Genie™ IG 200i, a two-in-one solution for quicker, more efficient inhaled product testing

Copley Scientific joins the Industries Forum of the Taskforce for Lung Health

Introducing Inhalytix®: a new solution for analysing and managing inhaler test data from Copley

Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio

New e-Training service from Copley for pharmaceutical testing

Copley Scientific releases new accessories for testing nebulisers with facemasks

Copley Scientific previews new apparatus for metered dose inhaler testing at DDL 25

Putting Inhalers to the Test

A short Q&A with our CEO, Mark Copley, On Inhaled Product Testing

Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products

Demonstrating Bioequivalence of Orally Inhaled Products

Optimising the Application of In Vitro Test Methods for the Demonstration of BE in OIPs

Characterizing the Performance of Metered Dose Inhalers with Add-On Devices: New Methods For Clinically Relevant Testing

Register your interest: Inhaler Testing Academy

Facemask Testing

Facemask Stand FMS

FMS to NGI Interface Accessory

Adult/Child/Infant Face Model

Filter Adapter and Holder

Next Generation Impactor NGI

NGI Induction Port

Breathing Simulator BRS 100i

Breath Actuation Controller BAC 100i

Label Printer

APSD of Nebulisers

DDU

Facemask Stand FMS

FMS to NGI Interface Accessory

Adult/Child/Infant Face Model

Filter Adapter and Holder

Next Generation Impactor NGI

NGI Induction Port

Breathing Simulator BRS 100i

Breath Actuation Controller BAC 100i

Label Printer

APSD of Nebulisers

DDU

Related Services

Training

Servicing

Support

Related News & Resources

Introducing the Copley Impactor Genie™ IG 200i, a two-in-one solution for quicker, more efficient inhaled product testing

Copley Scientific joins the Industries Forum of the Taskforce for Lung Health

Introducing Inhalytix®: a new solution for analysing and managing inhaler test data from Copley

Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio

New e-Training service from Copley for pharmaceutical testing

Copley Scientific releases new accessories for testing nebulisers with facemasks

Copley Scientific previews new apparatus for metered dose inhaler testing at DDL 25

Putting Inhalers to the Test

A short Q&A with our CEO, Mark Copley, On Inhaled Product Testing

Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products

Demonstrating Bioequivalence of Orally Inhaled Products

Optimising the Application of In Vitro Test Methods for the Demonstration of BE in OIPs

Characterizing the Performance of Metered Dose Inhalers with Add-On Devices: New Methods For Clinically Relevant Testing